{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,12]],"date-time":"2026-02-12T10:07:46Z","timestamp":1770890866991,"version":"3.50.1"},"reference-count":25,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2015,8,11]],"date-time":"2015-08-11T00:00:00Z","timestamp":1439251200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"name":"Medical Science Project of Zhejiang Province","award":["2013KYB045"],"award-info":[{"award-number":["2013KYB045"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clin Transl Oncol"],"published-print":{"date-parts":[[2015,10]]},"DOI":"10.1007\/s12094-015-1309-8","type":"journal-article","created":{"date-parts":[[2015,8,10]],"date-time":"2015-08-10T12:21:19Z","timestamp":1439209279000},"page":"835-839","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":32,"title":["Metabolic syndrome is an independent prognostic factor for endometrial adenocarcinoma"],"prefix":"10.1007","volume":"17","author":[{"given":"J.","family":"Ni","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"T.","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"L.","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"F.","family":"Che","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Y.","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"H.","family":"Shou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Yu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2015,8,11]]},"reference":[{"issue":"6","key":"1309_CR1","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1002\/ijc.10974","volume":"104","author":"AS Furberg","year":"2003","unstructured":"Furberg AS, Thune I. Metabolic abnormalities (hypertension, hyperglycemia and overweight), lifestyle (high energy intake and physical inactivity) and endometrial cancer risk in a Norwegian cohort. Int J Cancer. 2003;104(6):669\u201376.","journal-title":"Int J Cancer"},{"issue":"1","key":"1309_CR2","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1055\/s-0029-1242998","volume":"28","author":"JJ Kim","year":"2010","unstructured":"Kim JJ, Chapman-Davis E. Role of progesterone in endometrial cancer. Semin Reprod Med. 2010;28(1):81\u201390.","journal-title":"Semin Reprod Med"},{"issue":"2","key":"1309_CR3","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1002\/ijc.22260","volume":"120","author":"T Bj\u00f8rge","year":"2007","unstructured":"Bj\u00f8rge T, Engeland A, Tretli S, Weiderpass E. Body size in relation to cancer of the uterine corpus in 1 million Norwegian women. Int J Cancer. 2007;120(2):378\u201383.","journal-title":"Int J Cancer"},{"issue":"20","key":"1309_CR4","doi-asserted-by":"crossref","first-page":"2607","DOI":"10.1200\/JCO.2012.48.2596","volume":"31","author":"VW Setiawan","year":"2013","unstructured":"Setiawan VW, Yang HP, Pike MC, McCann SE, Yu H, Xiang YB, et al. Type I and II endometrial cancers: have they different risk factors? J Clin Oncol. 2013;31(20):2607\u201318.","journal-title":"J Clin Oncol"},{"key":"1309_CR5","doi-asserted-by":"crossref","first-page":"2384","DOI":"10.1158\/1055-9965.EPI-11-0715","volume":"20","author":"CM Friedenreich","year":"2011","unstructured":"Friedenreich CM, Biel RK, Lau DC, Csizmadi I, Coumeya KS, Magliocco AM, et al. Case\u2013control study of the metabolic syndrome and metabolic risk factors for endometrial cancer. Cancer Epidemiol Biomarkers Prev. 2011;20:2384\u201395.","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"1309_CR6","doi-asserted-by":"crossref","first-page":"884","DOI":"10.1093\/annonc\/mdq464","volume":"22","author":"V Rosato","year":"2011","unstructured":"Rosato V, Zucchetto A, Bosetti C, Dal Maso L, Montella M, Pelucchi C, et al. Metabolic syndrome and endometrial cancer risk. Ann Oncol. 2011;22:884\u20139.","journal-title":"Ann Oncol"},{"issue":"11","key":"1309_CR7","doi-asserted-by":"crossref","first-page":"2402","DOI":"10.2337\/dc12-0336","volume":"35","author":"K Esposito","year":"2012","unstructured":"Esposito K, Chiodini P, Colao A, Lenzi A, Giugliano D. Metabolic syndrome and risk of cancer: a systematic review and meta-analysis. Diabetes Care. 2012;35(11):2402\u201311.","journal-title":"Diabetes Care"},{"key":"1309_CR8","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1111\/j.1464-5491.2006.01858.x","volume":"23","author":"KG Alberti","year":"2006","unstructured":"Alberti KG, Zimmet P, Shaw J. Metabolic syndrome\u2014a new world-wide definition. A consensus statement from the international diabetes federation. Diabet Med. 2006;23:469\u201380.","journal-title":"Diabet Med"},{"issue":"3","key":"1309_CR9","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1038\/modpathol.3880051","volume":"13","author":"ME Sherman","year":"2000","unstructured":"Sherman ME. Theories of endometrial carcinogenesis: a multidisciplinary approach. Mod Pathol. 2000;13(3):295\u2013308.","journal-title":"Mod Pathol"},{"issue":"1","key":"1309_CR10","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/0090-8258(83)90111-7","volume":"15","author":"JV Bokhman","year":"1983","unstructured":"Bokhman JV. Two pathogenetic types of endometrial carcinoma. Gynecol Oncol. 1983;15(1):10\u20137.","journal-title":"Gynecol Oncol"},{"issue":"4","key":"1309_CR11","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1677\/erc.0.0070227","volume":"7","author":"G Emons","year":"2000","unstructured":"Emons G, Fleckenstein G, Hinney B, Huschmand A, Heyl W. Hormonal interactions in endometrial cancer. Endocr Relat Cancer. 2000;7(4):227\u201342.","journal-title":"Endocr Relat Cancer"},{"issue":"29","key":"1309_CR12","doi-asserted-by":"crossref","first-page":"4783","DOI":"10.1200\/JCO.2006.06.7173","volume":"24","author":"JL Hecht","year":"2006","unstructured":"Hecht JL, Mutter GL. Molecular and pathologic aspects of endometrial carcinogenesis. J Clin Oncol. 2006;24(29):4783\u201391.","journal-title":"J Clin Oncol"},{"issue":"16","key":"1309_CR13","doi-asserted-by":"crossref","first-page":"1640","DOI":"10.1161\/CIRCULATIONAHA.109.192644","volume":"120","author":"KG Alberti","year":"2009","unstructured":"Alberti KG, Eckel RH, Grundy SM, Zimmet PZ, Cleeman JI, Donato KA, et al. International Diabetes Federation Task Force on Epidemiology and Prevention; National Heart, Lung, and Blood Institute; American Heart Association; World Heart Federation; International Atherosclerosis Society; International Association for the Study of Obesity. Harmonizing the metabolic syndrome: a joint interim statement of the International Diabetes Federation Task Force on Epidemiology and Prevention; National Heart, Lung, and Blood Institute; American Heart Association; World Heart Federation; International Atherosclerosis Society; and International Association for the Study of Obesity. Circulation. 2009;120(16):1640\u20135.","journal-title":"Circulation"},{"issue":"3","key":"1309_CR14","doi-asserted-by":"crossref","first-page":"s817","DOI":"10.1093\/ajcn\/86.3.817S","volume":"86","author":"JR Zhou","year":"2007","unstructured":"Zhou JR, Blackburn GL, Walker WA. Symposium introduction: metabolic syndrome and the onset of cancer. Am J Clin Nutr. 2007;86(3):s817\u20139.","journal-title":"Am J Clin Nutr"},{"issue":"5","key":"1309_CR15","doi-asserted-by":"crossref","first-page":"1505","DOI":"10.2353\/ajpath.2006.051090","volume":"169","author":"S Cowey","year":"2006","unstructured":"Cowey S, Hardy RW. The metabolic syndrome: a high-risk state for cancer? Am J Pathol. 2006;169(5):1505\u201322.","journal-title":"Am J Pathol"},{"issue":"8","key":"1309_CR16","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1093\/aje\/kwj284","volume":"164","author":"L Lund Haheim","year":"2006","unstructured":"Lund Haheim L, Wisl\u00f8ff TF, Holme I, Nafstad P. Metabolic syndrome predicts prostate cancer in a cohort of middle-aged Norwegian men followed for 27\u00a0years. Am J Epidemiol. 2006;164(8):769\u201374.","journal-title":"Am J Epidemiol"},{"issue":"12","key":"1309_CR17","doi-asserted-by":"crossref","first-page":"2391","DOI":"10.1158\/1055-9965.EPI-06-0391","volume":"15","author":"T St\u00fcrmer","year":"2006","unstructured":"St\u00fcrmerT Buring JE, Lee IM, Gaziano JM, Glynn RJ. Metabolic abnormalities and risk for colorectal cancer in the physicians\u2019 health study. Cancer Epidemiol Biomarkers Prev. 2006;15(12):2391\u20137.","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"issue":"3","key":"1309_CR18","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1677\/ERC-07-0132","volume":"14","author":"AE Cust","year":"2007","unstructured":"Cust AE, Kaaks R, Friedenreich C, Bonnet F, Laville M, Tj\u00f8nneland A, et al. Metabolic syndrome, plasma lipid, lipoprotein and glucose levels, and endometrial cancer risk in the European Prospective Investigation into Cancer and Nutrition (EPIC). Endocr Relat Cancer. 2007;14(3):755\u201367.","journal-title":"Endocr Relat Cancer"},{"issue":"8","key":"1309_CR19","doi-asserted-by":"crossref","first-page":"892","DOI":"10.1093\/aje\/kwq006","volume":"171","author":"T Bj\u00f8rge","year":"2010","unstructured":"Bj\u00f8rge T, Stocks T, Lukanova A, Tretli S, Selmer R, Manjer J, et al. Metabolic syndrome and endometrial carcinoma. Am J Epidemiol. 2010;171(8):892\u2013902.","journal-title":"Am J Epidemiol"},{"issue":"2","key":"1309_CR20","first-page":"128","volume":"45","author":"HF Shou","year":"2010","unstructured":"ShouHF Ni J, Zhu T, Chen JH, Zhang X, Xu XX, et al. Association between endometrial cancer and metabolic syndrome. Zhonghua Fu Chan Ke Za Zhi. 2010;45(2):128\u201331.","journal-title":"Zhonghua Fu Chan Ke Za Zhi"},{"issue":"4","key":"1309_CR21","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1158\/1055-9965.EPI-07-2686","volume":"17","author":"MJ Gunter","year":"2008","unstructured":"Gunter MJ, Hoover DR, Yu H, Wassertheil-Smoller S, Manson JE, Li J, et al. A prospective evaluation of insulin and insulin-like growth factor-I as risk factors for endometrial cancer. Cancer Epidemiol Biomarkers Prev. 2008;17(4):921\u20139.","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"issue":"12","key":"1309_CR22","doi-asserted-by":"crossref","first-page":"2656","DOI":"10.1002\/ijc.22578","volume":"120","author":"AE Cust","year":"2007","unstructured":"Cust AE, Allen NE, Rinaldi S, Dossus L, Friedenreich C, Olsen A, et al. Serum levels of C-peptide, IGFBP-1 and IGFBP-2 and endometrial cancer risk; results from the European Prospective Investigation into Cancer and Nutrition. Int J Cancer. 2007;120(12):2656\u201364.","journal-title":"Int J Cancer"},{"issue":"2","key":"1309_CR23","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1002\/ijc.11544","volume":"108","author":"A Lukanova","year":"2004","unstructured":"Lukanova A, Zeleniuch-Jacquotte A, Lundin E, Micheli A, Arslan AA, Rinaldi S, et al. Prediagnostic levels of C-peptide, IGF-I, IGFBP -1, -2 and -3 and risk of endometrial cancer. Int J Cancer. 2004;108(2):262\u20138.","journal-title":"Int J Cancer"},{"issue":"8","key":"1309_CR24","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1038\/nrc1408","volume":"4","author":"EE Calle","year":"2004","unstructured":"Calle EE, Kaaks R. Overweight, obesity and cancer: epidemiological evidence and proposed mechanisms. Nat Rev Cancer. 2004;4(8):579\u201391.","journal-title":"Nat Rev Cancer"},{"issue":"5","key":"1309_CR25","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1007\/s00125-006-0207-6","volume":"49","author":"K Rapp","year":"2006","unstructured":"Rapp K, Schroeder J, Klenk J, Ulmer H, Concin H, Diem G, et al. Fasting blood glucose and cancer risk in a cohort of more than 140,000 adults in Austria. Diabetologia. 2006;49(5):945\u201352.","journal-title":"Diabetologia"}],"container-title":["Clinical and Translational Oncology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12094-015-1309-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s12094-015-1309-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12094-015-1309-8","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,8,29]],"date-time":"2019-08-29T05:57:17Z","timestamp":1567058237000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s12094-015-1309-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,8,11]]},"references-count":25,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2015,10]]}},"alternative-id":["1309"],"URL":"https:\/\/doi.org\/10.1007\/s12094-015-1309-8","relation":{},"ISSN":["1699-048X","1699-3055"],"issn-type":[{"value":"1699-048X","type":"print"},{"value":"1699-3055","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,8,11]]}}}